Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gastrointestinal immune function is the sum of activities carried out by specialized immune cells, epithelial barriers, and microbial metabolites within the gut to mediate defense against pathogens, promote tolerance to commensal bacteria and dietary antigens, maintain mucosal integrity, and balance immune activation versus tolerance[2][3][6]. Key cell types include T cells (e.g., Th17, Treg), B cells producing IgA, macrophages, dendritic cells, innate lymphoid cells, and epithelial cells[1][3][6]. Major molecular mediators are cytokines (such as interleukin-22, interleukin-17, TNF-α, IL-10), pattern recognition receptors like Toll-like receptors (TLRs), and metabolites such as short-chain fatty acids (SCFAs)[2][4][5][6][7]. Dysregulated GI immune function is central to conditions like inflammatory bowel disease, food allergy, infections, and colorectal cancer[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastrointestinal immune function.